158 related articles for article (PubMed ID: 20736131)
1. Anti-Müllerian hormone serum levels predict response to controlled ovarian hyperstimulation but not embryo quality or pregnancy outcome in oocyte donation.
Riggs R; Kimble T; Oehninger S; Bocca S; Zhao Y; Leader B; Stadtmauer L
Fertil Steril; 2011 Jan; 95(1):410-2. PubMed ID: 20736131
[TBL] [Abstract][Full Text] [Related]
2. The use of anti-Müllerian hormone and antral follicle count to predict the potential of oocytes and embryos.
Majumder K; Gelbaya TA; Laing I; Nardo LG
Eur J Obstet Gynecol Reprod Biol; 2010 Jun; 150(2):166-70. PubMed ID: 20223579
[TBL] [Abstract][Full Text] [Related]
3. Repetitive oocyte donation does not decrease serum anti-Müllerian hormone levels.
Bukulmez O; Li Q; Carr BR; Leader B; Doody KM; Doody KJ
Fertil Steril; 2010 Aug; 94(3):905-12. PubMed ID: 19631321
[TBL] [Abstract][Full Text] [Related]
4. Circulating basal anti-Müllerian hormone levels as predictor of ovarian response in women undergoing ovarian stimulation for in vitro fertilization.
Nardo LG; Gelbaya TA; Wilkinson H; Roberts SA; Yates A; Pemberton P; Laing I
Fertil Steril; 2009 Nov; 92(5):1586-93. PubMed ID: 18930213
[TBL] [Abstract][Full Text] [Related]
5. Anti-Müllerian hormone testing is useful for individualization of stimulation protocols in oocyte donors.
Nakhuda GS; Douglas NC; Thornton MH; Guarnaccia MM; Lobo R; Sauer MV
Reprod Biomed Online; 2010 Jan; 20(1):42-7. PubMed ID: 20158986
[TBL] [Abstract][Full Text] [Related]
6. Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction.
Al-Azemi M; Killick SR; Duffy S; Pye C; Refaat B; Hill N; Ledger W
Hum Reprod; 2011 Feb; 26(2):414-22. PubMed ID: 21147822
[TBL] [Abstract][Full Text] [Related]
7. Anti-Müllerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection.
Wunder DM; Guibourdenche J; Birkhäuser MH; Bersinger NA
Fertil Steril; 2008 Dec; 90(6):2203-10. PubMed ID: 18291376
[TBL] [Abstract][Full Text] [Related]
8. Random anti-Müllerian hormone (AMH) is a predictor of ovarian response in women with elevated baseline early follicular follicle-stimulating hormone levels.
Buyuk E; Seifer DB; Younger J; Grazi RV; Lieman H
Fertil Steril; 2011 Jun; 95(7):2369-72. PubMed ID: 21497340
[TBL] [Abstract][Full Text] [Related]
9. Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes.
Styer AK; Gaskins AJ; Brady PC; Sluss PM; Chavarro JE; Hauser RB; Toth TL
Fertil Steril; 2015 Nov; 104(5):1153-61.e1-7. PubMed ID: 26315051
[TBL] [Abstract][Full Text] [Related]
10. Antimüllerian hormone as a predictor of controlled ovarian hyperstimulation outcome: comparison of two commercial immunoassay kits.
Lee JR; Kim SH; Jee BC; Suh CS; Kim KC; Moon SY
Fertil Steril; 2011 Jun; 95(8):2602-4. PubMed ID: 21315333
[TBL] [Abstract][Full Text] [Related]
11. Using anti-Müllerian hormone to identify a good prognosis group in women of advanced reproductive age.
Fridén B; Sjöblom P; Menezes J
Aust N Z J Obstet Gynaecol; 2011 Oct; 51(5):411-5. PubMed ID: 21988118
[TBL] [Abstract][Full Text] [Related]
12. Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm injection patients.
Elgindy EA; El-Haieg DO; El-Sebaey A
Fertil Steril; 2008 Jun; 89(6):1670-6. PubMed ID: 17658520
[TBL] [Abstract][Full Text] [Related]
13. Anti-Müllerian hormone as an independent predictor of twin versus singleton pregnancy in fresh cycles.
Tal R; Seifer DB; Khanimov M; Schwartz E; Grazi RV; Malter HE
Reprod Biomed Online; 2013 Apr; 26(4):360-7. PubMed ID: 23419793
[TBL] [Abstract][Full Text] [Related]
14. The role of anti-Müllerian hormone assessment in assisted reproductive technology outcome.
Broer SL; Mol B; Dólleman M; Fauser BC; Broekmans FJ
Curr Opin Obstet Gynecol; 2010 Jun; 22(3):193-201. PubMed ID: 20407372
[TBL] [Abstract][Full Text] [Related]
15. Serum antimüllerian hormone/müllerian-inhibiting substance appears to be a more discriminatory marker of assisted reproductive technology outcome than follicle-stimulating hormone, inhibin B, or estradiol.
Hazout A; Bouchard P; Seifer DB; Aussage P; Junca AM; Cohen-Bacrie P
Fertil Steril; 2004 Nov; 82(5):1323-9. PubMed ID: 15533354
[TBL] [Abstract][Full Text] [Related]
16. Serum anti-Müllerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproduction technology cycles.
Lee TH; Liu CH; Huang CC; Wu YL; Shih YT; Ho HN; Yang YS; Lee MS
Hum Reprod; 2008 Jan; 23(1):160-7. PubMed ID: 18000172
[TBL] [Abstract][Full Text] [Related]
17. [Usefulness of inhibin B, serum progesterone, and AMH concentrations obtained during controlled ovarian hyperstimulation (COH) in predicting ovarian response and oocyte quality].
Dewailly D
J Gynecol Obstet Biol Reprod (Paris); 2006 Sep; 35(5 Pt 2):2S44-2S46. PubMed ID: 17057624
[TBL] [Abstract][Full Text] [Related]
18. Anti-Müllerian hormone for the assessment of ovarian response in GnRH-antagonist-treated oocyte donors.
Polyzos NP; Stoop D; Blockeel C; Adriaensen P; Platteau P; Anckaert E; Smitz J; Devroey P
Reprod Biomed Online; 2012 May; 24(5):532-9. PubMed ID: 22417669
[TBL] [Abstract][Full Text] [Related]
19. Relevance of anti-Mullerian hormone measurement in a routine IVF program.
Gnoth C; Schuring AN; Friol K; Tigges J; Mallmann P; Godehardt E
Hum Reprod; 2008 Jun; 23(6):1359-65. PubMed ID: 18387961
[TBL] [Abstract][Full Text] [Related]
20. Basal level of anti-Müllerian hormone is associated with oocyte quality in stimulated cycles.
Ebner T; Sommergruber M; Moser M; Shebl O; Schreier-Lechner E; Tews G
Hum Reprod; 2006 Aug; 21(8):2022-6. PubMed ID: 16679324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
